Last reviewed: June 7, 2026
Last updated: June 7, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Yes, your body creates glucagon-like peptide-1 (GLP-1) on its own—specifically in your pancreas and small intestine—but the amount your body produces differs from person to person. Research shows that people with obesity and type 2 diabetes often have lower GLP-1 secretion patterns, which may explain why appetite regulation becomes harder over time. PlexusDx helps identify whether your natural GLP-1 production matches your weight loss goals.
Where Your Body Naturally Produces GLP-1
GLP-1 originates in two main locations: your pancreatic islet cells and your intestinal L-cells, which line the small intestine. When you eat, especially foods containing carbohydrates and fats, these cells receive signals to release GLP-1 directly into your bloodstream. The hormone then travels throughout your body to regulate blood sugar, slow stomach emptying, and send fullness signals to your brain.
The amount of GLP-1 your body produces depends on meal composition, meal timing, and your individual genetics. Some people's intestinal L-cells release GLP-1 more readily in response to food, while others show muted responses. This natural variation in GLP-1 secretion helps explain why some individuals maintain stable weight while others struggle with constant hunger despite eating similar amounts.
How GLP-1 Controls Hunger and Blood Sugar
Your naturally produced GLP-1 works through multiple pathways to reduce appetite and stabilize blood glucose. It slows the rate at which your stomach empties food into your small intestine, keeping you satisfied longer after meals. Simultaneously, GLP-1 stimulates your pancreas to release insulin when blood sugar rises, preventing dangerous glucose spikes.
The hormone also crosses the blood-brain barrier and activates receptors in your hypothalamus, the region controlling hunger and satiety. People with lower baseline GLP-1 production often experience weaker satiety signals, leading to overeating and difficulty achieving calorie deficits. This biological difference is not a personal failure—it reflects how your genes influence metabolic regulation.
Why Some Bodies Don't Produce Enough GLP-1
Genetic variations affect how efficiently your intestinal L-cells and pancreatic cells produce and release GLP-1. The GLP1R rs6923761 genetic variant, for example, influences how responsive your GLP-1 receptors are to the hormone your body makes. Additional variants in the GIPR gene affect glucose-dependent insulinotropic polypeptide signaling, which works alongside GLP-1 to regulate metabolism.
Obesity itself can reduce GLP-1 secretion over time, creating a cycle where lower hormone production makes weight loss harder. Studies show that individuals with obesity produce approximately 30–50% less GLP-1 in response to meals compared to lean individuals. Environmental factors like chronic stress, poor sleep, and sedentary behavior also suppress GLP-1 signaling, compounding the biological challenge.
When Supplemental GLP-1 Therapy Makes Sense
If your body's natural GLP-1 production is insufficient to support your weight loss goals, supplemental GLP-1 therapy bridges the gap. Compounded semaglutide—a synthetic form of GLP-1—mimics your body's hormone at higher, more consistent levels. This approach allows your brain's appetite centers to receive stronger fullness signals, making calorie deficits sustainable without constant willpower.
PlexusDx offers compounded semaglutide injections starting at $149 per month, with no insurance required and HSA/FSA eligibility. The Precision Peptide Genetic Test ($99 add-on) maps how your specific genetic variants in GLP1R, GIPR, FTO, and MC4R pathways influence your natural GLP-1 production and response. This personalized insight helps determine whether supplementation aligns with your metabolic profile and weight loss strategy.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Does everyone's body produce the same amount of GLP-1?
No. GLP-1 production varies significantly based on genetics, body composition, and lifestyle. People with obesity often produce 30–50% less GLP-1 than lean individuals, and genetic variants in GLP1R and GIPR genes influence your baseline secretion capacity. PlexusDx's Precision Peptide Genetic Test identifies your specific production patterns across 14 metabolic pathways.
Can diet or exercise increase my body's natural GLP-1 production?
Yes, regular aerobic exercise and increased fiber intake from whole foods may modestly enhance GLP-1 secretion over weeks to months. However, genetic factors set a ceiling on how much you can naturally boost production. If your baseline capacity is low, supplemental therapy provides a faster, more reliable path to appetite control than lifestyle changes alone.
Is compounded semaglutide as effective as my body's natural GLP-1?
Compounded semaglutide achieves higher, more stable blood levels than your body typically produces, making it more potent at suppressing appetite and regulating blood sugar. It works through identical GLP-1 receptors as your natural hormone, but delivers consistent doses that mimic sustained, elevated GLP-1 signaling. PlexusDx's formulations from licensed 503A pharmacies provide reliable bioavailability.
What are the side effects of taking supplemental GLP-1 if my body already makes it?
Your body handles supplemental GLP-1 safely because it uses the same receptor pathways as your natural hormone. Common mild effects—nausea, constipation, fatigue—typically resolve within weeks as your system adapts. Serious adverse events are rare at therapeutic doses. Your PlexusDx provider monitors tolerance and adjusts your treatment to minimize discomfort.
How does the Precision Peptide Genetic Test measure my natural GLP-1 production?
The test identifies genetic variants in your GLP1R, GIPR, FTO, and MC4R genes that directly influence GLP-1 secretion, receptor sensitivity, and metabolic regulation. It maps your peptide pathway profile across 49 peptides and 150+ genetic insights, revealing whether low natural production is likely a factor in your weight struggles. This $99 add-on (after your first treatment month) personalizes your therapy strategy.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Does Ozempic Guarantee Weight Loss? Insights into Effectiveness and Usage
Understanding the Relationship Between Dosage and Volume: How Many ml is .5 mg Semaglutide?